AMNEAL PHARMACEUTICALS, INC. (AMRX) Gross profit 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual gross profit history from SEC filings — each fiscal year as reported.
$1.1BFY2025 · since FY2016: $597.5M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +9.1% |
| FY2024 | $1.0B | +24.4% |
| FY2023 | $820.6M | +4.6% |
| FY2022 | $784.7M | +2.0% |
| FY2021 | $769.0M | +22.4% |
| FY2020 | $628.4M | +78.0% |
| FY2019 | $353.0M | -50.7% |
| FY2018 | $716.4M | +36.2% |
| FY2017 | $526.2M | -11.9% |
| FY2016 | $597.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice